Business Context and Reporting Period
Company: Smith & Nephew plc
Reporting Period: Fiscal year ended December 31, 2009
Business Overview: A global medical devices company operating in three primary segments: Orthopaedics (57% of revenue), Endoscopy (21%), and Advanced Wound Management (22%). The company is incorporated in England and Wales, with shares listed on the London Stock Exchange and American Depositary Shares (ADSs) traded on the New York Stock Exchange.
Key Financial Metrics
| Metric ($ millions) | 2009 | 2008 | Change |
|---|---|---|---|
| Revenue | 3,772 | 3,801 | (1%) |
| Underlying Revenue Growth | 2% | 6% | - |
| Trading Profit | 857 | 776 | 10% |
| Trading Profit Margin | 22.7% | 20.4% | +230 bps |
| Operating Profit | 723 | 630 | 15% |
| Attributable Profit | 472 | 377 | 25% |
| Adjusted Attributable Profit | 580 | 493 | 18% |
| Basic EPS | 53.4p | 42.6p | 25% |
| Adjusted EPS (EPSA) | 65.6p | 55.6p | 18% |
| Cash Generated from Operations | 1,030 | 815 | 26% |
| Net Debt | (943) | (1,332) | Improvement of $389m |
Note: Trading Profit and Adjusted Attributable Profit are non-GAAP measures used by management to assess long-term trends, excluding acquisition costs, restructuring, and impairments.
Material Changes vs. Prior Period
- Revenue Decline: Reported revenue decreased by 1% to $3.772 billion. This was driven by a 3% negative impact from foreign currency translation (weakening of Sterling, Euro, and Australian Dollar against the USD), which offset 2% underlying organic growth.
- Profitability Expansion: Despite flat reported revenue, Operating Profit increased 15% to $723 million. Trading Profit Margin improved to 22.7% from 20.4% in 2008, driven by cost management initiatives (Earnings Improvement Programme) and favorable product mix.
- Segment Performance:
- Orthopaedics: Revenue flat (-1% reported, +1% underlying). Trading profit margin improved to 23.8%.
- Endoscopy: Revenue flat (-1% reported, +1% underlying). Trading profit margin improved to 23.9%.
- Advanced Wound Management: Revenue flat (0% reported, +6% underlying). Trading profit margin improved significantly to 18.9%.
- Balance Sheet: Net debt reduced by $389 million to $943 million, aided by strong operating cash flow and a $137 million cash inflow from the settlement of the Plus Orthopedics acquisition price adjustment.
Guidance, Outlook, and Risks
- Outlook: Management expects Orthopaedics Reconstruction to grow at the market rate in 2010, with continued improvement in Europe. Endoscopy is expected to see strong growth in the repair segment, though capital equipment sales recovery remains uncertain. Advanced Wound Management is expected to grow above the market rate.
- Strategic Focus: Continued focus on margin improvement, efficiency, and investment in growth opportunities including biologics and emerging markets (e.g., China).
- Key Risks:
- Currency: Significant exposure to exchange rate fluctuations (USD, Sterling, Euro, Swiss Franc).
- Regulatory/Legal: Ongoing litigation regarding macrotextured knee components (approx. $128m insurance recovery sought); investigations into Foreign Corrupt Practices Act (FCPA) compliance; patent disputes (e.g., with Kinetic Concepts regarding NPWT).
- Economic Conditions: Potential for continued deferral of elective procedures and pricing pressures due to global economic conditions.
Investor Verification Checklist
- Insurance Recovery: Verify the status of the $128 million claim against excess insurance carriers regarding macrotextured knee revisions.
- FCPA Investigation: Monitor the outcome of the ongoing SEC and DOJ investigation regarding potential Foreign Corrupt Practices Act violations by distributors.
- Plus Settlement: Confirm the finalization of the Plus Orthopedics purchase price adjustment and the impact on future goodwill amortization.
- Currency Hedging: Review the effectiveness of the company's hedging strategy given the 3% negative currency impact on revenue.
- Patent Litigation: Track the appeal process regarding the Kinetic Concepts patent infringement verdict in the US foam product case.